secwatch.observer — SEC 8-K summary
======================================

Issuer:     ORAMED PHARMACEUTICALS INC. (ORMP)
CIK:        0001176309
Form:       8-K
Filed at:   2024-10-29T23:59:59+00:00
Accession:  0001213900-24-091795
Event type: debt
Sentiment:  neutral
Materiality: 0.35
Item codes: 8.01
LLM model:  deepseek-v4-flash:cloud@v2

Oramed receives ~$1M prepayment on Scilex Tranche A Note; outstanding reduced to $80.2M
--------------------------------------------------------------------------------

- Received ~$1,000,000 mandatory prepayment on Tranche A Note from Scilex on Oct 24, 2024.
- After payment, $80,200,000 of original $101.875M principal repaid or refinanced.
- Payment represents 70% of net cash proceeds from Scilex debt/equity financings.
- Original Tranche A Note issued Sep 2023; $22.5M exchanged for Tranche B Notes in Oct 2024.
- $2.5M of principal exchanged for royalty purchase agreement interest.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1176309/000121390024091795/0001213900-24-091795-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1176309/000121390024091795/ea0219080-8k_oramed.htm
  HTML page:      https://secwatch.observer/filing/0001213900-24-091795

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer